Frailty Peaks During Midcourse Chemotherapy in Non-Hodgkin Lymphoma Patients
A multicenter observational study in China found that frailty among patients receiving chemotherapy for non-Hodgkin lymphoma peaked at the third ...
A multicenter observational study in China found that frailty among patients receiving chemotherapy for non-Hodgkin lymphoma peaked at the third ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.